J J Sánchez-Barriga1. 1. Dirección de Investigación Operativa de Epidemiología, Dirección General de Epidemiología, Secretaría de Salud, Ciudad de México, México. Electronic address: jsanchez@dgepi.salud.gob.mx.
Abstract
BACKGROUND: In Mexico, there has been an upward trend in mortality rates from colorectal cancer (CRC) over the past three decades. This tumor is ranked among the ten most prevalent causes of morbidity from malignancies in Mexico. AIMS: To determine the mortality trends by socioeconomic region and by state, and to establish the relative risk between both educational level and socioeconomic region with mortality from CRC within the time frame of 2000-2012. MATERIALS AND METHODS: Records of mortality associated with colorectal cancer were obtained. Rates of mortality by state and by socioeconomic region were calculated, along with the strength of association (obtained through the Poisson regression) between both socioeconomic region and educational level and the mortality from CRC. RESULTS: A total of 45,487 individuals died from CRC in Mexico from 2000 to 2012. Age-adjusted mortality rates per 100,000 inhabitants increased from 3.9 to 4.8. Baja California, Baja California Sur, and Sonora had the highest mortality from CRC. Individuals with no school or incomplete elementary school had a higher risk of dying from this cancer (RR of 3.57, 95% CI: 3.46-3.68). Region 7 had the strongest association with mortality from CRC (Mexico City: RR was 2.84, 95% CI: 2.39-3.37 [2000] and 3.32, 95% CI: 2.89-3.82 [2012]). CONCLUSIONS: In Mexico, the age-adjusted mortality rates per 100,000 inhabitants that died from CRC increased from 3.9 to 4.8 in the study period, using the world population age distribution as the standard. Baja California, Baja California Sur, and Sonora had the highest mortality from CRC. Mexico City, which was socioeconomic region 7, had the strongest association with mortality from CRC.
BACKGROUND: In Mexico, there has been an upward trend in mortality rates from colorectal cancer (CRC) over the past three decades. This tumor is ranked among the ten most prevalent causes of morbidity from malignancies in Mexico. AIMS: To determine the mortality trends by socioeconomic region and by state, and to establish the relative risk between both educational level and socioeconomic region with mortality from CRC within the time frame of 2000-2012. MATERIALS AND METHODS: Records of mortality associated with colorectal cancer were obtained. Rates of mortality by state and by socioeconomic region were calculated, along with the strength of association (obtained through the Poisson regression) between both socioeconomic region and educational level and the mortality from CRC. RESULTS: A total of 45,487 individuals died from CRC in Mexico from 2000 to 2012. Age-adjusted mortality rates per 100,000 inhabitants increased from 3.9 to 4.8. Baja California, Baja California Sur, and Sonora had the highest mortality from CRC. Individuals with no school or incomplete elementary school had a higher risk of dying from this cancer (RR of 3.57, 95% CI: 3.46-3.68). Region 7 had the strongest association with mortality from CRC (Mexico City: RR was 2.84, 95% CI: 2.39-3.37 [2000] and 3.32, 95% CI: 2.89-3.82 [2012]). CONCLUSIONS: In Mexico, the age-adjusted mortality rates per 100,000 inhabitants that died from CRC increased from 3.9 to 4.8 in the study period, using the world population age distribution as the standard. Baja California, Baja California Sur, and Sonora had the highest mortality from CRC. Mexico City, which was socioeconomic region 7, had the strongest association with mortality from CRC.
Authors: José María Remes-Troche; Gabriela Hinojosa-Garza; Priscilla Espinosa-Tamez; Arturo Meixueiro-Daza; Peter Grube-Pagola; Katherine Van Loon; Michael B Potter; Martin Lajous Journal: Fam Pract Date: 2020-07-23 Impact factor: 2.290
Authors: Max J Schmulson; Jazmin Chiu-Ugalde; Adolfo Sáez-Ríos; Aurelio López-Colombo; Gualberto J Mateos-Pérez; José María Remes-Troche; Sergio Sobrino-Cossio; Julio C Soto-Pérez; José L Tamayo de la Cuesta; Oscar T Teramoto-Matsubara; Juan C López-Alvarenga Journal: J Clin Gastroenterol Date: 2020-04 Impact factor: 3.174